Technical Data
Vimentin is the most common member of intermediate filament (IF) family and one of the main components in cytoskeleton structure. It is expressed during cell development and differentiation in a variety of mescencymal cells and cell types derived from mesoderm (1). Vimentin is essential in the role of cell integrity and cytoskeletal stability. The reorganization of Vimentin, similar to all IF proteins, occurs during different stages of the cell cycle and cell signaling by a site-specific phosphorylation (serine and threonine residues) (2). In particular, p21-activated kinase (PAK) phosphorylates at Ser25, Ser38, Ser50, Ser65 and Ser72 which induces Vimentin specific reorganization (3). During cytokinesis, Vimentin is regulated by Rho-kinase (ROCK) and Aurora B through phosphorylation at Ser38 and Ser72 (4).

Suitable for use in Western Blot, Immunoprecipitation and Immunohistochemistry. Other applications not tested.

Recommended Dilution:
Western Blot: 1:500
Immunoprecipitation: 1:15
Immunohistochemistry: 1:100-1:200; Staining pattern is cytoplasmic
Optimal dilutions to be determined by the researcher.

Positive Control:

Storage and Stability:
May be stored at 4C for short-term only. For long-term storage, aliquot and store at -20C. Aliquots are stable for at least 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Manufactured incorporating RabMAb technology under Epitomics US patents, No 5,675,063 and 7,429,487, owned by Abcam.
100ul4C (-20C Glycerol)Blue IceHumanRabbit
Not determined
Recombinant human Vimentin protein. MW of Antigen: 57kD.
Supplied as a liquid in 0.1% sodium azide, 0.05% BSA, before the addition of glycerol to 40%.
Recognizes human Vimentin. Species Crossreactivity: Mouse, rat.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Eriksson, J.E., et al., Curr. Opin. Cell Biol. 4: 99-104 (1992). 2. Inagaki, M., et al., Nature 328: 649-652 (1987). 3. Goto, H., et al., Genes Cells 7: 91-97 (2002). 4. Goto, H., et al., J. Biol. Chem. 273(19): 11,728-11,736 (1998).